These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Management of pharmacologically induced neuromuscular blockade using peripheral nerve stimulation. Loyola R; Dreher HM Dimens Crit Care Nurs; 2003; 22(4):157-64; quiz 165-6. PubMed ID: 12893991 [TBL] [Abstract][Full Text] [Related]
25. Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents. Hoyt JW New Horiz; 1994 Feb; 2(1):48-55. PubMed ID: 7922429 [TBL] [Abstract][Full Text] [Related]
27. The decision to use succinylcholine for critically ill patients should not be based on duration of time in the intensive care unit alone. Bittner EA; Martyn JAJ; Gronert GA Anesth Analg; 2013 May; 116(5):1182. PubMed ID: 23606469 [No Abstract] [Full Text] [Related]
29. Clinical uses and controversies of neuromuscular blocking agents in infants and children. Martin LD; Bratton SL; O'Rourke PP Crit Care Med; 1999 Jul; 27(7):1358-68. PubMed ID: 10446832 [TBL] [Abstract][Full Text] [Related]
30. Development of a policy for patients receiving neuromuscular blocking agents. Earl G; McMahon MB; Bartley M; Mancini W; Becker S J Trauma Nurs; 1997; 4(3):76-81. PubMed ID: 9407819 [TBL] [Abstract][Full Text] [Related]
31. Neuromuscular blocking agents in the management of respiratory failure. Indications and treatment guidelines. Sapirstein A; Hurford WE Crit Care Clin; 1994 Oct; 10(4):831-43. PubMed ID: 8000929 [TBL] [Abstract][Full Text] [Related]
32. An algorithm for train-of-four monitoring in patients receiving continuous neuromuscular blocking agents. Jones SK Dimens Crit Care Nurs; 2003; 22(2):50-7; quiz 58-9. PubMed ID: 12649615 [TBL] [Abstract][Full Text] [Related]
33. Sedation and pain control in the critically ill patient maintained on continuous neuromuscular blockade. Esch NJ Crit Care Nurs Q; 1995 Aug; 18(2):85-95. PubMed ID: 7621098 [TBL] [Abstract][Full Text] [Related]
36. Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine. Shapiro BA; Warren J; Egol AB; Greenbaum DM; Jacobi J; Nasraway SA; Schein RM; Spevetz A; Stone JR Crit Care Med; 1995 Sep; 23(9):1601-5. PubMed ID: 7664564 [TBL] [Abstract][Full Text] [Related]
37. [Use of neuromuscular blockers in the critical patient]. Sandiumenge A; Anglés R; Martínez-Melgar JL; Torrado H; Med Intensiva; 2008 Feb; 32 Spec No. 1():69-76. PubMed ID: 18405540 [TBL] [Abstract][Full Text] [Related]
38. Pharmacology of neuromuscular blocking agents in the intensive care unit. Hanson CW Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926 [TBL] [Abstract][Full Text] [Related]